Brand Names In 2008: Can Industry Pilot Its Way Out Of Trouble?
Executive Summary
Industry may shoulder some of the burden of testing proprietary drug names this year under a pilot program included in the renewal of the Prescription Drug User Fee Act, but with that may come some clarity in a subjective field that so far has lacked detailed guidance from FDA